Reconciliation disputes are usually what delay pharma payments, so the notice should attach a clear ledger and separate undisputed dues from disputed credit notes. MSME units supplying marketing companies use Samadhaan; distributors with cheque dues use Section 138; agreements often have arbitration clauses.
Pharmaceuticals and pharma distribution in Indore
Indore is Madhya Pradesh’s commercial capital, with pharma units in Pithampur, soya processors in Dewas and a wholesale cloth market in MT Cloth Market and Siyaganj. Pharma distributors and stockists are a common source of delayed dues, and the city’s Facilitation Council route under the MSMED Act is well used by Udyam-registered manufacturers.
Manufacturers sell to marketing companies on 45 to 90 day credit; stockists and distributors carry brand dues against schemes, expiry returns and credit notes that are reconciled slowly.
Proof to collect
Typically purchase orders, batch-wise invoices, GRNs or stockist acknowledgements, scheme and credit-note records, and the distribution agreement.
- Avoid: unsigned credit notes and scheme adjustments
- Avoid: expiry and breakage returns with no agreed policy
- Avoid: loan-licence work without a written manufacturing agreement
- Avoid: distribution agreements with an arbitration clause nobody read
Forums in Indore
| Route | Forum |
|---|---|
| Section 138 (cheque bounce) | Judicial Magistrate First Class courts, Indore, for Section 138 |
| Summary suit / recovery suit | District Court, Indore, and its Commercial Court for recovery suits |
| MSME Samadhaan | Madhya Pradesh Micro and Small Enterprises Facilitation Council (detail) |
| Arbitration | As per the contract clause |
How FundRaksha works for pharmaceuticals and pharma distribution suppliers in Indore
- Free assessment of the documents your trade produces.
- Notice within 24 hours, itemising invoices, disputed and undisputed amounts and interest.
- Negotiation and documented settlement.
- Filing in Indore or before the Council if needed.
30% on recovery, nothing upfront.